Advertisement
YOU ARE HERE: LAT HomeCollectionsSynbiotics Corp
IN THE NEWS

Synbiotics Corp

FEATURED ARTICLES
BUSINESS
May 28, 1987
Synbiotics Corp. and International Minerals & Chemical Corp. have signed an agreement in principle designed to speed commercialization of Synbiotics' monoclonal antibody technology. According to terms of the proposal, IMC will contribute a minimum of $6.75 million to Synbiotics during the next five years in return for the marketing rights to some of Synbiotics animal health products. IMC also will acquire common stock and warrants from Synbiotics.
ARTICLES BY DATE
BUSINESS
March 29, 1993
Nature of business: Makes diagnostic tests; therapeutic, vaccine products for small animals. Total employees: 115 In Orange County: 20 Stock listing in The Times: On NASDAQ "Synbio" Ticker symbol: "SBIO" Friday's stock close: $4 One-week change: None Analyst review: "Synbiotics is an intriguing company.
Advertisement
BUSINESS
June 4, 1987
Synbiotics Corp. has sold 1.5 million shares of common stock at $8.50 per share, less than the $11 price that the company had anticipated. The lower price was linked to generally bad market conditions that were generated Monday when the Food and Drug Administration refused to allow Genentech, a San Francisco-based biotechnology company, to market a heart-treatment drug.
BUSINESS
September 25, 1985
Eileen Skaletsky joined Synbiotics Corp., a Rancho Bernardo-based biomedical firm.
BUSINESS
May 10, 1989
Synbiotics Corp. in San Diego said A.M. (Don) MacKinnon has joined the board of directors of the biotechnology company. MacKinnon is the retired president and chief operating officer of Ciba-Geigy Corp., a developer and manufacturer of agricultural chemicals, pharmaceuticals, dyes, plastics and specialty chemicals.
BUSINESS
May 10, 1989
Synbiotics Corp. in San Diego said A.M. (Don) MacKinnon has joined the board of directors of the biotechnology company. MacKinnon is the retired president and chief operating officer of Ciba-Geigy Corp., a developer and manufacturer of agricultural chemicals, pharmaceuticals, dyes, plastics and specialty chemicals.
BUSINESS
August 27, 1987
Synbiotics Corp. confirmed Wednesday that a unit of SmithKline Beckman Corp. of Philadelphia has increased its holdings in Synbiotics to 280,000 shares, to 8.1% of the total outstanding. The most recent purchase by SmithKline's S.R. One Ltd. venture capital unit was for 80,000 shares on Aug. 13 at $8.25 per share, Synbiotics chief executive Ed Maggio said. SmithKline bought its other 200,000 shares at Synbiotics' 1.75 million-share public stock offering June 3, he said.
BUSINESS
June 4, 1987
Synbiotics Corp. has sold 1.5 million shares of common stock at $8.50 per share, less than the $11 price that the company had anticipated. The lower price was linked to generally bad market conditions that were generated Monday when the Food and Drug Administration refused to allow Genentech, a San Francisco-based biotechnology company, to market a heart-treatment drug.
BUSINESS
May 28, 1987
Synbiotics Corp. and International Minerals & Chemical Corp. have signed an agreement in principle designed to speed commercialization of Synbiotics' monoclonal antibody technology. According to terms of the proposal, IMC will contribute a minimum of $6.75 million to Synbiotics during the next five years in return for the marketing rights to some of Synbiotics animal health products. IMC also will acquire common stock and warrants from Synbiotics.
BUSINESS
January 29, 1987
Gregory A. Soulds has been promoted to vice president of marketing and sales for Synbiotics Corp.
Los Angeles Times Articles
|